ATE196470T1 - Piperidinylamino tricyclische derivate als substanz-p antagoniste - Google Patents
Piperidinylamino tricyclische derivate als substanz-p antagonisteInfo
- Publication number
- ATE196470T1 ATE196470T1 AT97306054T AT97306054T ATE196470T1 AT E196470 T1 ATE196470 T1 AT E196470T1 AT 97306054 T AT97306054 T AT 97306054T AT 97306054 T AT97306054 T AT 97306054T AT E196470 T1 ATE196470 T1 AT E196470T1
- Authority
- AT
- Austria
- Prior art keywords
- piperidinylamino
- chem
- alkoxy
- tricyclic derivatives
- disorder
- Prior art date
Links
- -1 PIPERIDINYLAMINO Chemical class 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 241000590002 Helicobacter pylori Species 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010042496 Sunburn Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 208000010643 digestive system disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229940037467 helicobacter pylori Drugs 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9600798 | 1996-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE196470T1 true ATE196470T1 (de) | 2000-10-15 |
Family
ID=11004463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97306054T ATE196470T1 (de) | 1996-08-14 | 1997-08-08 | Piperidinylamino tricyclische derivate als substanz-p antagoniste |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5972930A (de) |
| EP (1) | EP0824100B1 (de) |
| AT (1) | ATE196470T1 (de) |
| BR (1) | BR9704352A (de) |
| CA (1) | CA2212784C (de) |
| DE (1) | DE69703143T2 (de) |
| DK (1) | DK0824100T3 (de) |
| ES (1) | ES2150739T3 (de) |
| GR (1) | GR3034775T3 (de) |
| MX (1) | MX9706196A (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20060653A1 (es) * | 2004-08-31 | 2006-09-27 | Glaxo Group Ltd | Derivados triciclicos condensados como moduladores del receptor 5-ht1 |
| RU2409582C2 (ru) * | 2004-08-31 | 2011-01-20 | Глэксо Груп Лимитед | Конденсированные трициклические производные для лечения психотических расстройств |
| EP3610890A1 (de) | 2012-11-14 | 2020-02-19 | The Johns Hopkins University | Verfahren und zusammensetzungen zur behandlung von schizophrenie |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232929A (en) * | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
| ES2092113T3 (es) * | 1991-06-20 | 1996-11-16 | Pfizer | Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno. |
| ATE208376T1 (de) * | 1992-08-19 | 2001-11-15 | Pfizer | Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen |
| IL111002A (en) * | 1993-09-22 | 1998-09-24 | Glaxo Group Ltd | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
| US6180647B1 (en) * | 1995-07-07 | 2001-01-30 | Pfizer Inc. | Substituted benzolactam compounds as substance P antagonists |
| TW340842B (en) * | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
-
1996
- 1996-08-14 MX MX9706196A patent/MX9706196A/es not_active IP Right Cessation
-
1997
- 1997-08-07 US US08/907,374 patent/US5972930A/en not_active Expired - Fee Related
- 1997-08-08 EP EP97306054A patent/EP0824100B1/de not_active Expired - Lifetime
- 1997-08-08 AT AT97306054T patent/ATE196470T1/de not_active IP Right Cessation
- 1997-08-08 DE DE69703143T patent/DE69703143T2/de not_active Expired - Fee Related
- 1997-08-08 ES ES97306054T patent/ES2150739T3/es not_active Expired - Lifetime
- 1997-08-08 DK DK97306054T patent/DK0824100T3/da active
- 1997-08-12 CA CA002212784A patent/CA2212784C/en not_active Expired - Fee Related
- 1997-08-13 BR BR9704352A patent/BR9704352A/pt not_active Application Discontinuation
-
1999
- 1999-07-12 US US09/351,011 patent/US6143767A/en not_active Expired - Fee Related
-
2000
- 2000-11-08 GR GR20000402464T patent/GR3034775T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR3034775T3 (en) | 2001-02-28 |
| DE69703143T2 (de) | 2001-03-22 |
| DK0824100T3 (da) | 2000-11-20 |
| DE69703143D1 (de) | 2000-10-26 |
| EP0824100B1 (de) | 2000-09-20 |
| CA2212784A1 (en) | 1998-02-14 |
| MX9706196A (es) | 1998-02-28 |
| US6143767A (en) | 2000-11-07 |
| US5972930A (en) | 1999-10-26 |
| ES2150739T3 (es) | 2000-12-01 |
| CA2212784C (en) | 2001-02-27 |
| EP0824100A1 (de) | 1998-02-18 |
| BR9704352A (pt) | 1999-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY114800A (en) | Substituted benzylaminopiperidine compounds | |
| DE69206820D1 (de) | 1,3-Dihydro-2H-Imidano 4,5-b-quinolin-2-ein Derivate als Phosphodiestenase Hemmer | |
| KR100366902B1 (ko) | 섭스턴스 ｐ 길항제로서 피페리디닐아미노메틸트리플루오로메틸 시클릭 에테르 화합물 | |
| LU91943I2 (fr) | Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®) | |
| ATE217623T1 (de) | Azindolethylaminderivate als nikotin-acetylcholin-rezeptor bindung verbindungen | |
| LU92113I2 (fr) | Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA) | |
| DE60138732D1 (de) | Muscarin-rezeptor-agonisten | |
| PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
| ATE196470T1 (de) | Piperidinylamino tricyclische derivate als substanz-p antagoniste | |
| DE69623580D1 (de) | 3-((5-Substituierte Benzyl)Amino)-2-Phenylpiperidine als Substance-P-Antagonisten | |
| EA200101109A1 (ru) | Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана | |
| SE8505369D0 (sv) | New thienopyridine derivatives, a process of preparation thereof and therapeutic compositions containing the same | |
| DE69703725D1 (de) | Tetrazolyl-substituierte Chinuclidine als Substanz P Antagonisten | |
| FI914219A0 (fi) | 3-(1h-indazol-3-yl)-4-pyridinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel. | |
| ES2193047T3 (es) | (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas. | |
| ES519530A0 (es) | Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas. | |
| ES2141134T3 (es) | Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. | |
| ID26809A (id) | Senyawa-senyawa turunan sianoiminokuinoksalin | |
| OA08045A (fr) | Nouveaux dérivés de l'isoxazoloquinoléinone, procédé et intermédiaires de préparation, application à titre de médicaments, et compositions les renferment. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |